ASX - By Stock
|
ADX |
Re:
Ann: Welchau-1 Well Discovers Condensate Rich Gas
|
|
Msir
|
427 |
126K |
6 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
427
|
126K
|
6
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Welchau-1 Well Discovers Condensate Rich Gas
|
|
Msir
|
427 |
126K |
6 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
427
|
126K
|
6
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
Msir
|
113 |
25K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
113
|
25K
|
4
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
Msir
|
113 |
25K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
113
|
25K
|
5
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
Msir
|
113 |
25K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
113
|
25K
|
0
|
|
ASX - By Stock
|
5GG |
Re:
Ann: Pentanet Extends Geforce NOW Alliance Agreement With Nvidia
|
|
Msir
|
29 |
12K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
29
|
12K
|
3
|
|
ASX - By Stock
|
5GG |
Re:
Ann: Pentanet Extends Geforce NOW Alliance Agreement With Nvidia
|
|
Msir
|
29 |
12K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
29
|
12K
|
1
|
|
ASX - By Stock
|
5GG |
Re:
Ann: Pentanet Extends Geforce NOW Alliance Agreement With Nvidia
|
|
Msir
|
29 |
12K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
13 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
13
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
7
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Msir
|
164 |
45K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
2
|
|
ASX - By Stock
|
CTT |
Re:
Ann: Sale of Shares - Statement
|
|
Msir
|
57 |
14K |
4 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
57
|
14K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury
|
|
Msir
|
127 |
50K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
127
|
50K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury
|
|
Msir
|
127 |
50K |
8 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
127
|
50K
|
8
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury
|
|
Msir
|
127 |
50K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
127
|
50K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury
|
|
Msir
|
127 |
50K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
127
|
50K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
Msir
|
153 |
34K |
0 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
153
|
34K
|
0
|
|
ASX - By Stock
|
CTT |
Re:
Ann: H1 FY24 Appendix 4D and Financial Report
|
|
Msir
|
107 |
27K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
107
|
27K
|
2
|
|
ASX - By Stock
|
CTT |
Re:
Ann: H1 FY24 Appendix 4D and Financial Report
|
|
Msir
|
107 |
27K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
107
|
27K
|
1
|
|
ASX - By Stock
|
CTT |
Re:
Ann: H1 FY24 Appendix 4D and Financial Report
|
|
Msir
|
107 |
27K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
107
|
27K
|
4
|
|
ASX - By Stock
|
CTT |
Re:
Ann: H1 FY24 Appendix 4D and Financial Report
|
|
Msir
|
107 |
27K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
107
|
27K
|
0
|
|
ASX - By Stock
|
CTT |
Re:
Ann: H1 FY24 Appendix 4D and Financial Report
|
|
Msir
|
107 |
27K |
3 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
107
|
27K
|
3
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Large-scale Saprolite Clay Outcrop identified at Pocos REE
|
|
Msir
|
101 |
19K |
3 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
101
|
19K
|
3
|
|
ASX - By Stock
|
DMP |
Re:
target price
|
|
Msir
|
16 |
6.1K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
DMP |
Re:
target price
|
|
Msir
|
16 |
6.1K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
DMP |
Re:
Ann: Trading Update
|
|
Msir
|
340 |
109K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
340
|
109K
|
2
|
|
ASX - By Stock
|
TNC |
Re:
Ann: TNC secures Glencore partnership - Cloncurry Copper Project
|
|
Msir
|
130 |
40K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
130
|
40K
|
1
|
|
ASX - By Stock
|
CBE |
Re:
Ann: BHP Signs 2024 Xplor Agreement with Cobre
|
|
Msir
|
114 |
40K |
4 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
114
|
40K
|
4
|
|
ASX - By Stock
|
I88 |
Re:
Ann: Corporate Presentation
|
|
Msir
|
12 |
5.6K |
10 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
12
|
5.6K
|
10
|
|
ASX - By Stock
|
CPM |
Re:
Ann: Brumby Ridge Copper Discovery confirmed - 71m @ 2.8% Cu
|
|
Msir
|
262 |
95K |
9 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
262
|
95K
|
9
|
|
ASX - By Stock
|
CPM |
Re:
Ann: Brumby Ridge Copper Discovery confirmed - 71m @ 2.8% Cu
|
|
Msir
|
262 |
95K |
6 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
262
|
95K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial
|
|
Msir
|
242 |
109K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
242
|
109K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial
|
|
Msir
|
242 |
109K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
242
|
109K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Msir
|
22K |
11M |
1 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
22K
|
11M
|
1
|
|
ASX - By Stock
|
NIS |
Re:
Ann: Allkem Technical Collaboration on Lithium Potential
|
|
Msir
|
154 |
44K |
4 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
154
|
44K
|
4
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Msir
|
1.1K |
518K |
4 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.1K
|
518K
|
4
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Msir
|
1.1K |
518K |
2 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.1K
|
518K
|
2
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Msir
|
1.1K |
518K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.1K
|
518K
|
1
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Msir
|
1.1K |
518K |
6 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.1K
|
518K
|
6
|
|
ASX - By Stock
|
CHN |
Re:
Big Buyer arrived
|
|
Msir
|
38 |
25K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
38
|
25K
|
1
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Msir
|
1.1K |
518K |
1 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
1.1K
|
518K
|
1
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
|
|
Msir
|
1.1K |
518K |
9 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
1.1K
|
518K
|
9
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Renewed Technical Progress Update
|
|
Msir
|
240 |
96K |
6 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
240
|
96K
|
6
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Dividend/Distribution - PLS
|
|
Msir
|
408 |
217K |
2 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
408
|
217K
|
2
|
|
ASX - By Stock
|
DMP |
Re:
Ann: Half Year 2023 Market Presentation
|
|
Msir
|
53 |
29K |
4 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
53
|
29K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
Msir
|
42K |
20M |
0 |
28/01/23 |
28/01/23 |
ASX - By Stock
|
42K
|
20M
|
0
|
|